Abpro Holdings, Inc. (ABP)
NASDAQ: ABP · Real-Time Price · USD
5.81
-0.56 (-8.79%)
At close: Dec 5, 2025, 4:00 PM EST
5.87
+0.06 (1.03%)
After-hours: Dec 5, 2025, 7:29 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Antibodies
183.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
183.00K